Clinical Trial Update: Efficay and Safety of Empagliflozin Versus Sitagliptin for the In-patient Management of Hyperglycemia [NA]

View source ↗

Summary

A completed clinical trial comparing empagliflozin to sitagliptin for inpatient management of hyperglycemia in type 2 diabetes, assessing efficacy and safety.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• Empagliflozin (empagliflozin)
• Januvia (sitagliptin)
• Jardiance (empagliflozin)
• Sitagliptin (sitagliptin)

Snippet

Sponsor: Medanta, The Medicity, India | Conditions: Type 2 Diabetes | NA | Status: COMPLETED